Product Details

Nexgard Spectra 19 mg / 4 mg Chewable Tablets for Dogs >3.5–7.5 kg

• MA holder: Boehringer Ingelheim Vetmedica Gmbh
• VM number: EU/2/14/177/004-006,017
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 14/01/2015
• Authorisation route: Centralised
• Active substances:
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V